No New Trial For Former InterMune CEO
The former CEO of InterMune Inc., convicted of fraudulently marketing the drug Actimmune to treat a deadly lung disease, was denied a new trial Monday after a California federal judge ruled...To view the full article, register now.
Already a subscriber? Click here to view full article